Qinghua Wang MD, PhD

Dr. Qinghua Wang, MD, PhD, is a leading endocrinologist and clinical researcher based in Shanghai, China, where he serves as a Professor in the Division of Endocrinology and Metabolism at Huashan Hospital, Medical School of Fudan University, and Deputy Director of the Endocrine Diabetes Research Institute at Fudan University. He is also the Founder, Chairman, and Chief Executive Officer of Innogen Pharmaceutical Co., Ltd., a biotechnology company focused on developing innovative therapies for diabetes and metabolic disorders.

Dr. Wang has dedicated over 25 years to translational research in metabolic diseases, with a particular emphasis on diabetes pathophysiology and therapeutics, including the development of novel agents such as GLP-1 receptor agonists. His work bridges basic science, clinical investigation, and translational medicine, aiming to translate laboratory discoveries into effective clinical treatments. In addition to his academic and industry leadership roles, Dr. Wang contributes to global research and advisory activities and is recognized as a keynote speaker at international endocrinology and diabetes conferences.